CD4 and HIV-1 infection: T cell responses against HCV are preserved by avoiding CD4+ T cell depletion due to progressive HIV-1 infection, indicating a potential immunologic benefit of treatment of HIV in coinfected individuals before CD4+ T cell counts fall below 300 cells per microliter, a threshold at the higher end of the current range where initiation of treatment is typically recommended.